Pharmaceutical Technology on MSN

MHRA approves Roche’s inavolisib for breast cancer

The approval enables the use of inavolisib in patients whose cancer has recurred during or after hormone therapy and has ...
Breast cancer remains a predominant global health challenge for women, with late-stage diagnosis being a key contributor to ...
Adaptive radiotherapy (ART) is transforming cancer treatment in India. With over 1.4 million cases reported annually, ART offers real-time precision therapy, improving survival rates and quality of ...
For some patients with the most common type of lung cancer, known as lung adenocarcinoma, there's new hope. In a new study ...
Discover Taurus and Cancer compatibility and see how this pair blends stability with emotion. Learn why Cancer and Taurus ...
Discover why Ideaya Biosciences, Inc. is rated a Buy for its promising oncology pipeline and upcoming catalysts. Click for my ...
Squamous cell carcinoma (SCC) of the bladder is a distinct and rarer form, accounting for approximately 2% to 5% of all bladder cancers in the U.S. It develops in the flat, thin squamous cells that ...
One in every 8 men in the United States will develop prostate cancer, according to prostate cancer statistics released by the American Cancer Society. In the US, advanced prostate cancer diagnoses ...
Cancer is challenging to treat, yet identifying individuals with greater risk of developing disease can assist with early detection and increased treatment efficacy. There are several types of risk ...
Identification of germline hereditary cancer syndrome variants and associated cancers in a healthcare biobank population. NuGenA (Nurse Led Genetic Counselling and Awareness): A proof-of-concept to ...
A hidden clue may explain why some mutated cells become cancerous and others don’t: how fast they divide. A new study from researchers at Sinai Health in Toronto reveals that the total time it takes ...